Magnetic nanoparticles: A novel platform for cancer theranostics

Drug Discovery Today

Volumn 19, Issue 4, 2014, Pages 474-481

  Singh, Abhalaxmi ^a   Sahoo, Sanjeeb K ^a  

^a INSTITUTE OF LIFE SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; DRUG CARRIER; FERRISTENE; FERUCARBOTRAN; FERUMOXSIL; FERUMOXYTOL; MAGNETIC NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; ANTINEOPLASTIC AGENT; FERRIC ION; FERRIC OXIDE; METAL NANOPARTICLE;

BIOCOMPATIBILITY; BIOSENSOR; BLADDER CANCER; BRAIN CANCER; CANCER DIAGNOSIS; CANCER THERANOSTICS; CANCER THERAPY; DRUG DELIVERY SYSTEM; GENE DELIVERY SYSTEM; HUMAN; HYDROGEL; HYPERTHERMIC THERAPY; IRON CHELATION; LEUKEMIA; MAGNETIC FIELD; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; PROSTATE CANCER; REVIEW; SOFT TISSUE SARCOMA; SURFACE PROPERTY; UROGENITAL TRACT CANCER; ANIMAL; DIAGNOSTIC USE; MAGNETISM; METABOLISM; NEOPLASMS;

ANIMALS; ANTINEOPLASTIC AGENTS; CONTRAST MEDIA; DRUG CARRIERS; FERRIC COMPOUNDS; HUMANS; MAGNETIC PHENOMENA; METAL NANOPARTICLES; NEOPLASMS;

EID: 84899573655     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2013.10.005     Document Type: Review

References (60)

1. S.H. Koenig, and K.E. Kellar Theory of 1/T1 and 1/T2 NMRD profiles of solutions of magnetic nanoparticles Magn. Reson. Med. 34 1995 227 233
2. C. Sun et al. Magnetic nanoparticles in MR imaging and drug delivery Adv. Drug Deliv. Rev. 60 2008 1252 1265
3. O. Veiseh et al. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging Adv. Drug Deliv. Rev. 62 2010 284 304
4. A. Akbarzadeh et al. Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine Nanoscale Res. Lett. 7 2012 144
5. C.S. Kumar, and F. Mohammad Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery Adv. Drug Deliv. Rev. 63 2011 789 808
6. M.A. Willard et al. Chemically prepared magnetic nanoparticles Int. Mater. Rev. 49 2004 125 170
7. A.K. Gupta, and M. Gupta Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications Biomaterials 26 2005 3995 4021
8. S.R. Wan et al. Size-controlled preparation of magnetite nanoparticles in the presence of graft copolymers J. Mater. Chem. 16 2006 298 303
9. V.I. Shubayev et al. Magnetic nanoparticles for theragnostics Adv. Drug Deliv. Rev. 61 2009 467 477
10. F. Dilnawaz et al. Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy Biomaterials 31 2010 3694 3706
11. J.R. McCarthy et al. Targeted delivery of multifunctional magnetic nanoparticles Nanomedicine 2 2007 153 167
12. M.A. Dobrovolskaia, and S.E. McNeil Immunological properties of engineered nanomaterials Nat. Nanotechnol. 2 2007 469 478
13. C. Sun et al. PEG-mediated synthesis of highly dispersive multifunctional superparamagnetic nanoparticles: their physicochemical properties and function in vivo ACS Nano 4 2010 2402 2410
14. A. Nel et al. Toxic potential of materials at the nanolevel Science 311 2006 622 627
15. H. Maeda Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects Bioconjug. Chem. 21 2010 797 802
16. X. Montet et al. Nanoparticle imaging of integrins on tumor cells Neoplasia 8 2006 214 222
17. A.L. Martin et al. Synthesis of bombesin-functionalized iron oxide nanoparticles and their specific uptake in prostate cancer cells J. Nanopart. Res. 12 2009 1599 1608
18. J.S. Jiang et al. A novel magnetic fluid based on starch-coated magnetite nanoparticles functionalized with homing peptide J. Nanopart. Res. 11 2009 1321 1330
19. J. Meng et al. LHRH-functionalized superparamagnetic iron oxide nanoparticles for breast cancer targeting and contrast enhancement in MRI Mater. Sci. Eng. C 29 2009 1467 1479
20. A.J. Cole et al. Cancer theranostics: the rise of targeted magnetic nanoparticles Trends Biotechnol. 29 2011 323 332
21. V.P. Torchilin Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery Biopolymers 90 2008 604 610
22. K.J. Widder et al. Magnetically responsive microspheres and other carriers for the biophysical targeting of antitumor agents Adv. Pharmacol. Chemother. 16 1979 213 271
23. J. Koda et al. A multicenter, phase 1/11 trial of hepatic intra-arterial delivery of doxorubicin hydrochloride adsorbed to magnetic targeted carriers in patients with hepatocellular carcinoma Eur. J. Cancer 38 2002 S18
24. C. Corot et al. Recent advances in iron oxide nanocrystal technology for medical imaging Adv. Drug Deliv. Rev. 58 2006 1471 1504
25. J.H. Lee et al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging Nat. Med. 13 2007 95 99
26. J. Shin et al. Hollow manganese oxide nanoparticles as multifunctional agents for magnetic resonance imaging and drug delivery Angew Chem. Int. Ed. Engl. 48 2009 321 324
27. H. Duan et al. Reexamining the effects of particle size and surface chemistry on the magnetic properties of iron oxide nanocrystals: new insights into spin disorder and proton relaxivity J. Phys. Chem. C 112 2008 8127 8131
28. Y.X. Wang Superparamagnetic iron oxide based MRI contrast agents: current status of clinical application Quant. Imaging Med. Surg. 1 2011 35 40
29. R.C. Semelka, and T.K. Helmberger Contrast agents for MR imaging of the liver Radiology 218 2001 27 38
30. C. Sun et al. In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes Small 4 2008 372 379
31. B. Chertok et al. Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors Biomaterials 29 2008 487 496
32. D. Högemann-Savellano et al. The transferrin receptor: a potential molecular imaging marker for human cancer Neoplasia 5 2003 495 506
33. E.A. Schellenberger et al. Magneto/optical annexin V, a multimodal protein Bioconjug. Chem. 15 2004 1062 1067
34. M.G. Harisinghani et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer N. Engl. J. Med. 348 2003 2491 2499
35. H. Shao et al. Magnetic nanoparticles and microNMR for diagnostic applications Theranostics 2 2012 55 65
36. J.M. Perez et al. Magnetic relaxation switches capable of sensing molecular interactions Nat. Biotechnol. 20 2002 816 820
37. H. Lee et al. Rapid detection and profiling of cancer cells in fine-needle aspirates Proc. Natl. Acad. Sci. U. S. A. 106 2009 12459 12464
38. J.B. Haun et al. Micro-NMR for rapid molecular analysis of human tumor samples Sci. Transl. Med. 3 2011 71ra16
39. S.K. Sahoo, and V. Labhasetwar Nanotech approaches to drug delivery and imaging Drug Discov. Today 8 2003 1112 1120
40. U. Zimmermann, and G. Pilwat Organ specific application of drugs by means of cellular capsule systems (author's transl) Z. Naturforsch. C 31 1976 732 736
41. A.S. Lubbe et al. Preclinical experiences with magnetic drug targeting: tolerance and efficacy Cancer Res. 56 1996 4694 4701
42. S.C. Goodwin et al. Single-dose toxicity study of hepatic intra-arterial infusion of doxorubicin coupled to a novel magnetically targeted drug carrier Toxicol. Sci. 60 2001 177 183
43. A. Singh et al. Composite polymeric magnetic nanoparticles for co-delivery of hydrophobic and hydrophilic anticancer drugs and MRI imaging for cancer therapy ACS Appl. Mater. Interfaces 3 2011 842 856
44. C.J. Sunderland et al. Targeted nanoparticles for detecting and treating cancer Drug Develop. Res. 67 2006 70 93
45. C. Sun et al. Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles Nanomedicine 3 2008 495 505
46. J. Deshane et al. Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2 J. Biol. Chem. 278 2003 4135 4144
47. O. Veiseh et al. Optical and MRI multifunctional nanoprobe for targeting gliomas Nano Lett. 5 2005 1003 1008
48. O. Veiseh et al. Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles Small 5 2009 256 264
49. S. Purushotham, and R.V. Ramanujan Thermoresponsive magnetic composite nanomaterials for multimodal cancer therapy Acta Biomater. 6 2010 502 510
50. K. Maier-Hauff et al. Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme J. Neurooncol. 81 2007 53 60
51. K. Maier-Hauff et al. Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme J. Neurooncol. 103 2011 317 324
52. A.M. Derfus et al. Remotely triggered release from magnetic nanoparticles Adv. Mater. 19 2007 3932 3936
53. T. Hoare et al. A magnetically triggered composite membrane for on-demand drug delivery Nano Lett. 9 2009 3651 3657
54. O. Boussif et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine Proc. Natl. Acad. Sci. U. S. A. 92 1995 7297 7301
55. Z. Medarova et al. In vivo imaging of siRNA delivery and silencing in tumors Nat. Med. 13 2007 372 377
56. D. Vainauska et al. A novel approach for nucleic acid delivery into cancer cells Medicina (Kaunas) 48 2012 324 329
57. P.M. Doraiswamy, and A.E. Finefrock Metals in our minds: therapeutic implications for neurodegenerative disorders Lancet Neurol. 3 2004 431 434
58. M. Li et al. In situ monitoring Alzheimer's disease beta-Amyloid aggregation and screening of Abeta inhibitors using a perylene probe Small 9 2012 52 55
59. S.J. Soenen, and M. De Cuyper Assessing iron oxide nanoparticle toxicity in vitro: current status and future prospects Nanomedicine 5 2010 1261 1275
60. W. Tilly et al. Temperature data and specific absorption rates in pelvic tumours: predictive factors and correlations Int. J. Hyperthermia 17 2001 172 188